Cargando…
Immediate transfection of patient-derived leukemia: a novel source for generating cell-based vaccines
BACKGROUND: The production of cell-based cancer vaccines by gene vectors encoding proteins that stimulate the immune system has advanced rapidly in model systems. We sought to develop non-viral transfection methods that could transform patient tumor cells into cancer vaccines, paving the way for rap...
Autores principales: | Gershan, Jill A, Johnson, Bryon D, Weber, James, Schauer, Dennis W, Natalia, Natalia, Behnke, Stephanie, Burns, Karen, Maloney, Kelly W, Warwick, Anne B, Orentas, Rimas J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182385/ https://www.ncbi.nlm.nih.gov/pubmed/15969754 http://dx.doi.org/10.1186/1479-0556-3-4 |
Ejemplares similares
-
Adoptive cellular therapy using bone marrow-derived T cells for the treatment of childhood leukemia
por: Gershan, Jill, et al.
Publicado: (2015) -
Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
por: Gershan, Jill, et al.
Publicado: (2013) -
Bone Marrow-derived CD8(+) T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy
por: Palen, Katie, et al.
Publicado: (2019) -
Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen
por: Zheng, Jin, et al.
Publicado: (2007) -
Chimeric engulfment receptors: A new cell therapy approach for SIV and HIV infection
por: Orentas, Rimas J.
Publicado: (2023)